↓ Skip to main content

Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study

Overview of attention for article published in BMC Musculoskeletal Disorders, January 2011
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
58 Mendeley